Showing results (41-50 of 8,997) with videos related to
Sort By:
Pageof 900
European Journal of Clinical Pharmacology|September 11, 2001
Fatal hepatoxicity secondary to nimesulideG Merlani, M Fox, H P Oehen, et al.European Journal of Clinical Pharmacology|September 11, 2001
Changes in the utilisation of lipid-lowering drugs over a 6-year period (1993-1998) in a Danish populationJ Larsen, M Andersen, J Kragstrup, et al.European Journal of Clinical Pharmacology|May 16, 2002
The role of CYP2C19 in amitriptyline N-demethylation in Chinese subjectsZhi-Ping Jiang, Yan Shu, Xiao-Ping Chen, et al.European Journal of Clinical Pharmacology|May 16, 2002
N-acetyltransferase 2 single-nucleotide polymorphisms and risk of gastric carcinomaJosé M Ladero, José A G Agúndez, Manuela Olivera, et al.European Journal of Clinical Pharmacology|May 16, 2002
Incidence and determinants of migraine prophylactic medication in the NetherlandsH Rahimtoola, H Buurma, C C Tijssen, et al.European Journal of Clinical Pharmacology|August 7, 2002
Initiation of oral anticoagulant therapy in orthopedic and surgical patients: an algorithm compared with routine dosingP M L A van den Bemt, M Beinema, E N van Roon, et al.European Journal of Clinical Pharmacology|April 11, 2001
Is diclofenac a valuable CYP2C9 probe in humans?S Morin, M A Loriot, J M Poirier, et al.European Journal of Clinical Pharmacology|April 17, 2003
Differences in flurbiprofen pharmacokinetics between CYP2C9*1/*1, *1/*2, and *1/*3 genotypesCraig R Lee, John A Pieper, Reginald F Frye, et al.European Journal of Clinical Pharmacology|April 17, 2003
Diosmin pretreatment affects bioavailability of metronidazoleK Rajnarayana, Mada S Reddy, Devarakonda R KrishnaEuropean Journal of Clinical Pharmacology|April 17, 2003
Under-prescribing of cardiovascular therapies for diabetes in primary careK E Bennett, D Williams, J FeelyPageof 900